Evidence map›Paper›PMID 37451174›Full record

SynthesisBrazilian journal of otorhinolaryngology

Effect of melatonin on otoprotection in rodents: a systematic review with meta-analysis.

Natália Lombardi Assumpção, Juliana Gusmão de Araújo, Lucieny Silva Martins Serra, Vanessa Veis Ribeiro, Maria Luiza Queiroz Sampaio, Andressa Alves Caram, André Luiz Lopes Sampaio

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Natália Lombardi AssumpçãoUniversidade de Brasília, Faculdade de Medicina, Laboratório de Pesquisa em Otorrinolaringologia, Brazil.
Juliana Gusmão de AraújoUniversidade de Brasília, Faculdade de Medicina, Laboratório de Pesquisa em Otorrinolaringologia, Brazil.
Lucieny Silva Martins SerraUniversidade de Brasília, Faculdade de Medicina, Laboratório de Pesquisa em Otorrinolaringologia, Brazil.
Vanessa Veis RibeiroUniversidade de Brasília, Faculdade de Ceilândia, Departamento de Fonoaudiologia, Brazil.
Maria Luiza Queiroz SampaioUniversidade de Brasília, Faculdade de Medicina, Laboratório de Pesquisa em Otorrinolaringologia, Brazil.
Andressa Alves CaramUniversidade de Brasília, Faculdade de Medicina, Laboratório de Pesquisa em Otorrinolaringologia, Brazil.
André Luiz Lopes SampaioUniversidade de Brasília, Faculdade de Medicina, Laboratório de Pesquisa em Otorrinolaringologia, Brazil. Electronic address: andresampaio@unb.br.
Universidade de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determinate the otoprotective efficacy of melatonin.in experimental models of rodents through a systematic review of the literature.

methodsAltogether, 154 articles were found in four databases. The PICOS strategy (Population, Intervention, Comparison, and Outcome) was used to define the eligibility criteria. Studies that met the inclusion criteria for the second step were included in a qualitative synthesis. Each study type was analyzed with the CAMARADES quality of assessment's checklist and the SYRCLE RoBS risk of bias.

resultsSeven articles were selected, and four were included in the meta-analysis. It was possible to obtain seven outcomes according to the standard auditory frequencies presented among the studies, considering a minimum of three standard frequencies. The outcomes analyzed were for the frequencies of 1500, 2000, 3000, 4000, 5000, 6000, and 8000 Hz.

conclusionMelatonin can provide protection against the ototoxic effects of cisplatin and aminoglycosides at 5000 Hz, 6000 Hz, and 8000 Hz, thereby minimizing the reduction in Otoacustic Emissions (OAE) amplitude. The same effect was not observed in the lower frequencies. Despite the limited number of studies that were evaluated, the results appeared consistent in higher frequencies. However, the methodology of the available studies did not meet the necessary methodological rigor that promotes the safe replicability of these studies.

Indexed as

MelatoninAnimalsCisplatinRodentiaCisplatinMelatoninMelatoninOtoprotectionOtotoxic agentsRodents

Identifiers

PMID37451174
PMCPMC10518499
OpenAlexW4383069848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.